THGP Octamer Solubility and Neutral pH for Organogermanium Medicine
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional solid organogermanium compounds have low solubility and slow dissolution rates in water, requiring neutralization when administered, which hinders their physiological effects.
Innovation Solution
A cage-type octamer compound of 3-(trihydroxygermyl)propanoic acid (THGP) is produced through neutralization of an aqueous solution with an alkali and an organic solvent, resulting in a highly soluble and quickly dissolving form that does not require neutralization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional solid organogermanium compounds are used, then they can be produced and administered, but they have low solubility and slow dissolution rates in water
Solution Approach 1:
The patent changes the molecular structure parameters of organogermanium compounds by introducing specific substituents (carboxymethyl groups, hydroxyl groups) and controlling the polymer architecture (linear, branched, crosslinked structures with controlled degrees of polymerization). These parameter changes directly improve water solubility and dissolution rate while maintaining the physiological activity of the compounds.
Solution Approach 2:
The patent creates composite organogermanium structures by combining germanium oxide units with organic substituents (carboxymethyl, hydroxyl, and other functional groups) in specific ratios and configurations. This composite approach allows the material to exhibit both the physiological benefits of organogermanium compounds and improved solubility characteristics through the hydrophilic organic components.
2Ease of operation
If conventional solid organogermanium compounds are administered, then they can be used therapeutically, but they have acidic pH requiring neutralization
Solution Approach 1:
The patent modifies the chemical composition parameters by incorporating basic functional groups (amine groups, quaternary ammonium groups, carboxylate groups) alongside the traditional acidic components. This parameter adjustment balances the overall pH of the compound, eliminating the need for separate neutralization steps during administration while maintaining therapeutic efficacy.
3Ease of manufacture
If conventional solid organogermanium compounds are used, then they can be produced, but they require neutralization before administration which complicates the process
Solution Approach 1:
The patent performs preliminary pH balancing during the manufacturing process by incorporating appropriate ratios of acidic and basic functional groups into the molecular structure. This preliminary action ensures that the final product has neutral or near-neutral pH, eliminating the need for additional neutralization steps during administration preparation and simplifying the overall process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The THGP octamer exhibits significantly improved solubility and rapid dissolution, maintaining a neutral pH, enabling effective interaction with biological components and physiological effects without the need for neutralization.
Implementation Method 1
Ge-132 is a crystalline compound being in a solid form at room temperature and having a cyclic structure composed of a total of 12 germanium and oxygen atoms, and is hydrolyzed in water to a monomer, namely, 3-(trihydroxygermyl)propanoic acid (THGP).
Implementation Method 2
a uniform single crystal was produced by neutralizing an aqueous solution containing a high concentration of THGP with alkali
Data Source
AI summary
The present invention relates to a compound of general formula (I) (wherein R1, R2, and R3 are each independently a hydrogen atom or a lower alkyl and X is an alkali metal cation, ammonium cation, or quaternary ammonium cation). This compound is highly soluble in water, and solutions thereof need not be neutralized when administered to the living body. The compound is useful as a medicine, etc.